-
Older people who report memory decline or show objective evidence of cognitive impairment are more likely to develop Alzheimer's disease and other forms of dementia over time.
-
Miller and colleagues, representing 29 study centers in the United States, reported the results of a Phase 2 clinical trial, assessing the impact of denosumab on bone density.
-
The authors provide a mini-primer on interstitial cystitis (IC), a condition that is known to be poorly diagnosed and treated in many circumstances.
-
-
Moll and colleagues from Amsterdam performed a subgroup analysis within their randomized clinical trial of women with polycystic ovary syndrome comparing metformin plus clomiphene treatment with clomiphene alone.
-
Glinert and colleagues from Israel report the use of photodynamic therapy to successfully ablate single feto-placental implantations in rats.
-
July of this year represented the 5-year anniversary of the publication of Gynecologic Oncology Group (GOG) protocol 178, a pivotal trial demonstrating the significant impact of 9 additional months of paclitaxel chemotherapy to women who had achieved a complete clinical response to primary therapy.
-
In the Issue: Ongoing safety review of tiotropium; raloxifene reduces the risk of endometrial cancer; one-day treatment with famciclovir may be as effective as 3-day treatment with valacyclovir; new Clinical Practice Guideline from the American College of Physicians regarding pharmacologic treatment for low bone density and osteoporosis; FDA Actions.
-
Cigarettes and pregnancy are a risky combination, and there is an abundance of data to indicate that perinatal outcome is improved if patients can abstain from smoking.
-
